InsidersTradesSigma
Track the Diamyd Medical AB stock price and the full directors' dealings record of the company, a listed equity based in Finland. Shares are quoted on the FI market, under the supervision of FIN-FSA. Operating in the Health Care sector, Diamyd Medical AB has recorded 0 public disclosures. Market capitalisation: €156.5m. The full history is free.
n/a
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Declarations0 total
No declarations found
0 of 0 declarations
About Diamyd Medical AB
Diamyd Medical AB is a Swedish biopharmaceutical company focused on developing treatments for type 1 diabetes. The company is listed on the Stockholm Stock Exchange (XSTO).